Planned and ongoing clinical trials: a status update from Cardialysis and the European Cardiovascular Research Institute (ECRI)

Chairpersons: P.W. Serruys, G.A. Van Es

Learning Objectives

  • To have an overview of upcoming and ongoing trials in the field of interventional cardiology
  • To learn about which clinical questions will be answered by the new trials
  • To get update on the status of the ongoing trials and the trial design of the future studies

Presentations available when logged in:

  • Introduction and objectives
  • GLOBAL LEADERS: the effectivenes of 1 month ticagrelor plus asparin followed by ticagrelor monotherapy in contemporary PCI
  • SYNTAX II: PCI of 3-vessel disease applying clinical, anatomical and functional parameters 3
  • ABSORB STEMI - TROFI II: the use of bioresorbable scaffolds in acute STEMI
  • Novel anticoagulants in the dual pathway strategy targeting both thrombin and platelets in interventional cardiology
  • SURTAVI: transaortic valve replacement compared to surgical aortic valve replacement in medium risk patients